Hyoscine skin patches for drooling dilate pupils and impair accommodation: Spectacle correction for photophobia and blurred vision may be warranted

Developmental Medicine and Child Neurology

Volumn 49, Issue 6, 2007, Pages 426-428

  Saeed, Manzar ^a   Henderson, Gladys ^b   Dutton, Gordon N ^a,c,d  

^a Tennent Institute of Ophthalmology   (United Kingdom)

^b MONKLANDS HOSPITAL   (United Kingdom)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^d GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPENTOLATE; SCOPOLAMINE;

ACCOMMODATION; ACCOMMODATION PARALYSIS; ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; BLURRED VISION; CASE STUDY; CEREBRAL PALSY; CONTROLLED STUDY; EYE DISEASE; FEMALE; HUMAN; HYPERSALIVATION; INTELLECTUAL IMPAIRMENT; MALE; MIOSIS; MYDRIASIS; PHOTOPHOBIA; PRIORITY JOURNAL; PUPIL REFLEX; QUADRIPLEGIA; REFRACTION ERROR; RETINOSCOPY; SCHOOL CHILD; SIDE EFFECT; SPECTACLES; TRANSDERMAL PATCH; VISUAL ACUITY; VISUAL IMPAIRMENT;

ACCOMMODATION, OCULAR; ADOLESCENT; CEREBRAL PALSY; CHILD; CYCLOPENTOLATE; EYE PROTECTIVE DEVICES; FEMALE; HUMANS; MALE; MUSCARINIC ANTAGONISTS; PHOTOPHOBIA; PRACTICE GUIDELINES; PUPIL DISORDERS; SCOPOLAMINE; SIALORRHEA; VISION DISORDERS; VISUAL ACUITY;

EID: 34249801511     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2007.00426.x     Document Type: Article

References (14)

1. Brei TJ. (2003) Management of drooling. Semin Pediatr Neurol. 10: 265-270.
2. Clissold S P, Heel RC. (1985) Transdermal hyoscine (scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 29: 189-207.
3. Lewis DW, Fontana C, Mehallick LK, Everett Y. (1994) Transdermal scopolamine for reduction of drooling in developmentally delayed children. Dev Med Child Neurol. 36: 484-486.
4. Talmi Y P, Finkelstein Y, Zohar Y. (1990) Reduction of salivary flow with transdermal scopolamine: A four-year experience. Otolaryngol Head Neck Surg. 103: 615-618.
5. Homick JL, Kohl RL, Reschke MF, Degioanni J, Cintron-Treviro NM. (1983) Transdermal scopolamine in the prevention of motion sickness: Evaluation of the time course of efficacy. Aviat Space Environ Med. 54: 994-1000.
6. Rodor F, Cottin C, Jouglard J. (1989) Transdermal scopolamine and mydriasis. Therapie. 44: 447-448.
7. Rosen NB. (1986) Accidental mydriasis from scopolamine patches. J Am Optom Assoc. 57: 541-542.
8. Parrott AC. (1989) Transdermal scopolamine: A review of its effects upon motion sickness, psychological performance and physiological functioning. Aviat Space Environ Med. 60: 1-9.
9. Adoh TO, Woodhouse JM. (1994) The Cardiff acuity test for measuring visual acuity development in toddlers. Vision Res. 34: 555-560.
10. McLelland JF, Saunders KJ. (2004) Accommodative lag using dynamic retinoscopy: Age norms for school-age children. Optom Vis Sci. 81: 929-933.
11. Agbeja AM, Dutton GN. (1987) Adie's syndrome as a cause of amblyopia. J Pediatr Ophthalmol Strabismus. 24: 176-177.
12. Priestley BS, Medine MM. (1951) Residual accommodation after cyclopentolate 1%. Am J Ophthalmol. 34: 572-575.
13. Gregg M, Woodhouse M, Pakeman VH, Sauders KJ, Gunter HL, Parker M, Fraser WI, Sastry P. (2001) Accommodation and refractive error in children with Down syndrome: Cross-section and longitudinal studies. Invest Ophthalmol Vis Sci. 42: 55-63.
14. Dale N, Sonksen P. (2002) Developmental outcome, including setback, in young children with severe visual impairment. Dev Med Child Neurol. 44: 613-622.